Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $98.28 USD
Change Today -0.87 / -0.88%
Volume 8.7M
As of 8:04 PM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for johnson & johnson (JNJ)

Year over year, Johnson & Johnson has been able to grow revenues from $71.3B USD to $74.3B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 30.61% to 29.54%. This was a driver that led to a bottom line growth from $13.8B USD to $16.3B USD.
Currency in
Millions of US Dollars
As of:Jan 01
Dec 30
Dec 29
Dec 28
4 Year
TOTAL REVENUES65,030.067,224.071,312.074,331.0
Cost of Goods Sold20,273.021,658.022,242.022,746.0
GROSS PROFIT44,757.045,566.049,070.051,585.0
Selling General & Admin Expenses, Total20,969.020,869.021,830.021,954.0
R&D Expenses7,548.07,665.08,183.08,494.0
OTHER OPERATING EXPENSES, TOTAL28,517.028,534.030,013.030,448.0
OPERATING INCOME16,240.017,032.019,057.021,137.0
Interest Expense-571.0-532.0-482.0-533.0
Interest and Investment Income91.
NET INTEREST EXPENSE-480.0-468.0-408.0-466.0
Currency Exchange Gains (Loss)-10.0-58.0-186.0-156.0
Other Non-Operating Income (Expenses)577.0618.0289.0-589.0
EBT, EXCLUDING UNUSUAL ITEMS16,327.017,124.018,752.019,926.0
Merger & Restructuring Charges-656.0---683.0--
Gain (Loss) on Sale of Investments----417.0--
Gain (Loss) on Sale of Assets------2,300.0
Other Unusual Items, Total-3,310.0-3,349.0-3,015.0-1,663.0
In Process R&D Expenses---1,163.0-580.0-178.0
Legal Settlements-3,310.0-1,218.0-2,276.0-1,253.0
EBT, INCLUDING UNUSUAL ITEMS12,361.013,775.015,471.020,563.0
Income Tax Expense2,689.03,261.01,640.04,240.0
Minority Interest in Earnings--339.0----
Earnings from Continuing Operations9,672.010,514.013,831.016,323.0
NET INCOME9,672.010,853.013,831.016,323.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS9,672.010,853.013,831.016,323.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS9,672.010,853.013,831.016,323.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $98.28 USD -0.87

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $25.95 USD +0.20
Novartis AG SFr.97.85 CHF -0.80
Pfizer Inc $34.34 USD +0.08
Roche Holding AG SFr.273.90 CHF -3.40
Procter & Gamble Co/The $79.97 USD -0.32
View Industry Companies

Industry Analysis


Industry Average

Valuation JNJ Industry Range
Price/Earnings 17.5x
Price/Sales 3.9x
Price/Book 4.1x
Price/Cash Flow 17.1x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at